Indications and uses
For the relief of hangovers associated with drinking alcohol.
For the relief of hangovers associated with drinking alcohol.
Age Dose Adults Chew one tablet with a large glass of water at bedtime after drinking alcohol. Repeat every two hours if necessary. However variation of these directions is acceptable and may be preferable. Best taken separately from meals.
Store under 86°F (30°C), no drug interactions, and non-drowsy.
Drug Facts
| Active Ingredients | Purpose | |
|---|---|---|
| The letters HPUS indicate that these ingredients are officially included in the Homeopathic Pharmacopeia of the United States. | ||
| Avena Sativa | 30C HPUS | To reduce hangovers |
| Capsicum Annuum | 30C HPUS | |
| Nux Vomica | 30C HPUS | |
| Veratrum Album | 30C HPUS | |
| Zinc Metallicum | 30C HPUS | |
For the relief of hangovers associated with drinking alcohol.
Do not use if the blister pack is broken.
Stop use and ask a doctor if symptoms persist for more than 3 days or worsen.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children.
| Age | Dose |
|---|---|
| Adults | Chew one tablet with a large glass of water at bedtime after drinking alcohol. Repeat every two hours if necessary. However variation of these directions is acceptable and may be preferable. Best taken separately from meals. |
Store under 86°F (30°C), no drug interactions, and non-drowsy.
Dextrose and separating agents magnesium stearate and silicon dioxide.
According to the Surgeon General, alcohol consumption by pregnant women can cause birth defects. Drink responsibly. Alcohol consumption impairs your ability to operate machinery.
Distributed to retailers by
L.C. Industries, Inc
Elk Grove Village, IL 60007
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ed912195-5da0-0f2f-6f4b-3ef17710cbe3 | Product name | 1 | 20140508 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 59672-0532-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-efcf-f424-e053-dadaa90a57ce | DRINK EASE™ |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 59672-0532-1 | Drink Ease | 32 in 1 BLISTER PACK | TABLET | 32 | 3 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 59672-0532 | DRINK EASE (AVENA SATIVA FLOWERING TOP, CAPSICUM, STRYCHNOS NUX-VOMICA SEED, VERATRUM ALBUM ROOT, AND ZINC) TABLET [LC INDUSTRIES] | 3 | Legacy NDC, 1 package rows | 20140828_cd1fe6e5-acf2-4eb2-80c1-164f999095ef.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Avena Sativa Flowering Top | ACTIVE INGREDIENT | MA9CQJ3F7F | 3 | |
| Capsicum | ACTIVE INGREDIENT | 00UK7646FG | 3 | |
| Strychnos Nux-Vomica Seed | ACTIVE INGREDIENT | 269XH13919 | 3 | |
| Veratrum Album Root | ACTIVE INGREDIENT | QNS6W5US1Z | 3 | |
| Zinc | ACTIVE INGREDIENT | J41CSQ7QDS | 3 | |
| Avena Sativa Flowering Top | ACTIVE MOIETY | MA9CQJ3F7F | 3 | |
| Capsicum | ACTIVE MOIETY | 00UK7646FG | 3 | |
| Strychnos Nux-Vomica Seed | ACTIVE MOIETY | 269XH13919 | 3 | |
| Veratrum Album Root | ACTIVE MOIETY | QNS6W5US1Z | 3 | |
| Zinc | ACTIVE MOIETY | J41CSQ7QDS | 3 | |
| Dextrose | INACTIVE INGREDIENT | IY9XDZ35W2 | 3 | |
| Magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | 3 | |
| Silicon Dioxide | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 59672-0532 | 59672-0532-1 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Avena Sativa Flowering Top | MA9CQJ3F7F | ACTIB |
| Capsicum | 00UK7646FG | ACTIB |
| Strychnos Nux-Vomica Seed | 269XH13919 | ACTIB |
| Veratrum Album Root | QNS6W5US1Z | ACTIB |
| Zinc | J41CSQ7QDS | ACTIB |
| Dextrose | IY9XDZ35W2 | IACT |
| Silicon Dioxide | ETJ7Z6XBU4 | IACT |
| Magnesium stearate | 70097M6I30 | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, DELAYED RELEASE / ORAL | 1190 mg | ||
| Dextrose | DEXTROSE | IY9XDZ35W2 | SYRUP / ORAL | 620 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / BUCCAL | 3 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | POWDER, FOR SUSPENSION / ORAL | 120 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TAMPON / VAGINAL | NA | ||
| Dextrose | DEXTROSE | IY9XDZ35W2 | INJECTION, SOLUTION / INTRAVENOUS | 51.7 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | SUSPENSION / ORAL | 64 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | CREAM / TOPICAL | NA | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE, EXTENDED RELEASE / ORAL | 117 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, LIQUID FILLED / ORAL | 106 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | WAFER / ORAL | 66 mg | ||
| Dextrose | DEXTROSE | IY9XDZ35W2 | TABLET, EXTENDED RELEASE / ORAL | 103.95 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | POWDER / ORAL | 25 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, CHEWABLE / ORAL | 127 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 47 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / TOPICAL | 6 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | SYSTEM / INTRAVITREAL | 0.02 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | FILM, EXTENDED RELEASE / TRANSDERMAL | 49 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | SUSPENSION / ORAL | 400 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | SUSPENSION, EXTENDED RELEASE / ORAL | 70 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | IMPLANT / INTRAVITREAL | NA | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | INHALANT / ORAL | 0.08 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | SUSPENSION, EXTENDED RELEASE / ORAL | 71 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, FOR SUSPENSION / ORAL | 220 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, COATED / ORAL | 184 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, COATED / ORAL | 176 mg | ||
| Dextrose | DEXTROSE | IY9XDZ35W2 | TABLET / SUBLINGUAL | 115.78 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | PELLET / ORAL | 34 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, EXTENDED RELEASE / ORAL | 173 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 2 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE / ORAL | 300 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | RING / VAGINAL | 2 mg | ||
| Dextrose | DEXTROSE | IY9XDZ35W2 | INJECTION / INTRAVENOUS | 5 %w/v | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, DELAYED RELEASE / ORAL | 144 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | LOZENGE / TRANSMUCOSAL | 100 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, DELAYED RELEASE PARTICLES / ORAL | 170 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET / SUBLINGUAL | 17.5 mg | ||
| Dextrose | DEXTROSE | IY9XDZ35W2 | POWDER / VAGINAL | 430 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 53 mg | ||
| Dextrose | DEXTROSE | IY9XDZ35W2 | TROCHE / ORAL | 903.5 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | DROPS / ORAL | NA | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TROCHE / ORAL | 315 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, EXTENDED RELEASE / ORAL | 450 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | SOLUTION / ORAL | 336 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, CHEWABLE / ORAL | 254 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | SUPPOSITORY / RECTAL | 14 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER / RESPIRATORY (INHALATION) | NA | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE / RESPIRATORY (INHALATION) | NA | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | FILM, SOLUBLE / ORAL | 2 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE / ORAL | 256.4 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | GRANULE / ORAL | 629 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, DELAYED RELEASE / ORAL | 3.2 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, COATED / ORAL | 3 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | SYSTEM / TRANSDERMAL | 35 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / DENTAL | 19 %w/w | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET / BUCCAL | 17.5 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, EXTENDED RELEASE / ORAL | 168 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 9 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, ORALLY DISINTEGRATING / ORAL | 187 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 241f2e67-bdc5-4829-8901-2c84929fa5e8 | cd1fe6e5-acf2-4eb2-80c1-164f999095ef | 2014-08-14 | Warnings | 241f2e67-bdc5-4829-8901-2c84929fa5e8 cd1fe6e5-acf2-4eb2-80c1-164f999095ef |
Adverse event summaries are temporarily unavailable. Other product information remains available.